(Q72008076)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7654430%20AND%20SRC:MED&resulttype=core&format=json

22 October 2019

title

Docetaxel (Taxotere) in advanced renal cell cancer. A phase II trial of the EORTC Early Clinical Trials Group (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7654430%20AND%20SRC:MED&resulttype=core&format=json

22 October 2019

Docetaxel (Taxotere) in advanced renal cell cancer. A phase II trial of the EORTC early clinical trials group (English)

1 reference

https://api.crossref.org/works/10.1016/0959-8049(94)90457-X

20 July 2024

main subject

phase II clinical trial

1 reference

1 reference

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A7654430

20 July 2024

author name string

U. Bruntsch

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A7654430

20 July 2024

B. Heinrich

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A7654430

20 July 2024

S. B. Kaye

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A7654430

20 July 2024

P. H. de Mulder

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A7654430

20 July 2024

A. van Oosterom

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A7654430

20 July 2024

R. Paridaens

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A7654430

20 July 2024

J. B. Vermorken

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A7654430

20 July 2024

J. Wanders

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A7654430

20 July 2024

H. Franklin

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A7654430

20 July 2024

M. Bayssas

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A7654430

20 July 2024

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=7654430

20 July 2024

publication date

1 January 1994

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7654430%20AND%20SRC:MED&resulttype=core&format=json

full work available at URL

22 October 2019

https://api.elsevier.com/content/article/PII:095980499490457X?httpAccept=text/xml

1 reference

https://api.crossref.org/works/10.1016/0959-8049(94)90457-X

https://api.elsevier.com/content/article/PII:095980499490457X?httpAccept=text/plain

20 July 2024

1 reference

https://api.crossref.org/works/10.1016/0959-8049(94)90457-X

European Journal of Cancer

20 July 2024

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7654430%20AND%20SRC:MED&resulttype=core&format=json

22 October 2019

volume

30A

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7654430%20AND%20SRC:MED&resulttype=core&format=json

22 October 2019

issue

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7654430%20AND%20SRC:MED&resulttype=core&format=json

22 October 2019

page(s)

1064-1067

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7654430%20AND%20SRC:MED&resulttype=core&format=json

CANCER of the kidney and ureter

22 October 2019

cites work

1

1 reference

https://api.crossref.org/works/10.1016/0959-8049(94)90457-X

Studies With RP 56976 (Taxotere): A Semisynthetic Analogue of Taxol

20 July 2024

3

1 reference

https://api.crossref.org/works/10.1016/0959-8049(94)90457-X

Phase I trial of Taxotere: five-day schedule

20 July 2024

8

1 reference

https://api.crossref.org/works/10.1016/0959-8049(94)90457-X

Phase I clinical trial of taxotere administered as either a 2-hour or 6-hour intravenous infusion

20 July 2024

9

1 reference

https://api.crossref.org/works/10.1016/0959-8049(94)90457-X

Coping with toxicities of docetaxel (Taxotere)

20 July 2024

11

1 reference

https://api.crossref.org/works/10.1016/0959-8049(94)90457-X

20 July 2024

Identifiers

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7654430%20AND%20SRC:MED&resulttype=core&format=json

22 October 2019

1 reference